The latest update is out from TrivarX Limited ( (AU:TRI) ).
TrivarX Limited has announced a collaboration with the US Department of Veterans Affairs and the Greater Los Angeles Research and Education Foundation to conduct a clinical trial using its single-channel ECG mental health screening algorithm. This trial aims to screen for major depressive episodes among veterans, potentially opening up significant commercialization opportunities for TrivarX’s technology. The trial, which will involve 60 patients, is expected to be completed within 12 weeks and could significantly impact the company’s market positioning by expanding its addressable market and improving mental health diagnostics for veterans.
More about TrivarX Limited
TrivarX Limited operates in the healthcare technology industry, focusing on innovative mental health solutions. The company specializes in developing algorithms for mental health screening, particularly using heart rate and heart rate variability metrics. Their market focus includes collaborations with healthcare organizations to enhance mental health diagnostics.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.4M
For detailed information about TRI stock, go to TipRanks’ Stock Analysis page.